|
donocco.. u make some valid points, but take a simplistic view of drug research costs, and the costs associated with marketing and supplying this drug .. sutent . to the world.
it costs the drug companies between 50-100k per patient to run clinical trials.. about 40 patients in a phase 1 / 100 patients in a phase 2 / and 200 -500 patients typically in a phase 3 for an oncology drug.
and that is just the trial cost/ this excludes any development /productions costs of the drug.
the costs for manufacturing mevacor..pennies as you say vs sutent.. dollars are minimal.
run
|